Kiora Pharmaceuticals Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Kiora Pharmaceuticals Inc.
- Former names
- Eyegate Pharmaceuticals Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Encinitas
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- KPRX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001372514
- EIN
- 98-0443284
Board of directors
-
Aron Shapiro · DirectorSince 2023
-
Brian M. Strem · Director · President and CEOSince 2023
-
Carmine N. Stengone · DirectorSince 2023
-
David Hollander · DirectorSince 2023
-
Erin Parsons · DirectorSince 2023
-
Kenneth L. Gayron · DirectorSince 2023
-
Lisa Walters-Hoffert · DirectorSince 2024
-
Paul G. Chaney · DirectorSince 2023
-
Praveen Tyle · DirectorSince 2023
Chief executives
Brian M. Strem
· President and CEO
Dates unknown
Director election results
Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.4%
-
98.6%
-
99.3%
Board connections
4 of this board's directors also sit on 4 other boards.
- via Carmine N. Stengone
- via Lisa Walters-Hoffert
- via Kenneth L. Gayron
- via Praveen Tyle
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 2026 | Brian M. Strem Director, Officer (President and CEO) | Shares withheld for tax | −1,869 | $2.66 | $4,972 |
| Jul 1, 2026 | Tosca Melissa Officer (CFO) | Shares withheld for tax | −911 | $2.66 | $2,423 |
| Apr 1, 2026 | Tosca Melissa Officer (CFO) | Shares withheld for tax | −929 | $1.95 | $1,812 |
| Apr 1, 2026 | Daniels Eric Joseph Officer (Chief Development Officer) | Shares withheld for tax | −929 | $1.95 | $1,812 |
| Apr 1, 2026 | Brian M. Strem Director, Officer (President and CEO) | Shares withheld for tax | −1,906 | $1.95 | $3,717 |
| Mar 6, 2026 | Daniels Eric Joseph Officer (Chief Development Officer) | Grant or award | +6,533 | — | — |
| Mar 6, 2026 | Brian M. Strem Director, Officer (President and CEO) | Grant or award | +16,733 | — | — |
| Mar 6, 2026 | Tosca Melissa Officer (CFO) | Grant or award | +6,533 | — | — |
| Mar 3, 2026 | Daniels Eric Joseph Officer (Chief Development Officer) | Shares withheld for tax | −238 | $2.02 | $481 |
| Mar 3, 2026 | Brian M. Strem Director, Officer (President and CEO) | Shares withheld for tax | −238 | $2.02 | $481 |
| Apr 1, 2025 | Tosca Melissa Officer (CFO) | Grant or award | +7,772 | — | — |
| Apr 1, 2025 | Daniels Eric Joseph Officer (Chief Development Officer) | Grant or award | +7,772 | — | — |
| Apr 1, 2025 | Brian M. Strem Director, Officer (President and CEO) | Grant or award | +15,941 | — | — |
| Sep 11, 2024 | Carmine N. Stengone Director | Open-market purchase | +1,250 | $3.68 | $4,600 |
| Sep 10, 2024 | Aron Shapiro Director | Open-market purchase | +3,000 | $3.60 | $10,800 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.